According to recent reports, more and more insurance companies may agree to pay for continuous glucose monitors in the next few years. In many cases, continuous monitors have been shown to improve diabetes care, and demand for this type of diabetic device is growing.
A variety of manufacturers make continuous monitors, including Dexcom Inc. and Abbott Laboratories. In American, lack of widespread insurance coverage has limited the appeal of these products, and most diabetics continue to use traditional testing methods.
Aaron Kowalskin, the research director of the Juvenile Diabetes Research Foundatio, reportedly commented: “There’s an aching need for these technologies. It’s incredible, the demand. But there are obstacles to people getting this technology.”
Last month, major US health insurance company Aetna Inc. agreed to provide cover for this type of device for diabetics under certain circumstances.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…